All Stories

  1. Cinacalcet as an alternative to phosphate therapy in X-linked hypophosphataemic rickets

    Article • Clinical Endocrinology, May 2017, Wiley

    Dr. Tarak Srivastava

  2. Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Aditi Gupta, Dr. Tarak Srivastava

  3. Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b

    Article • Pediatric Nephrology, December 2015, Springer Science + Business Media

    Dr. Tarak Srivastava

  4. Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group

    Article • BMC Nephrology, July 2015, Springer Science + Business Media

    Dr. Tarak Srivastava

  5. Serum 25-vitamin D level is lower in African American compared to Caucasian children

    Article • Bone Abstracts, June 2015, Bioscientifica

    Dr. Tarak Srivastava

  6. Ethanol at low concentrations protects glomerular podocytes through alcohol dehydrogenase and 20-HETE

    Article • Prostaglandins & Other Lipid Mediators, January 2015, Elsevier

    Dr. Tarak Srivastava

  7. Fluid flow shear stress upregulates prostanoid receptor EP2 but not EP4 in murine podocytes

    Article • Prostaglandins & Other Lipid Mediators, July 2013, Elsevier

    Dr. Tarak Srivastava

  8. Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium

    Article • Pediatric Nephrology, April 2013, Springer Science + Business Media

    Dr Michelle Rheault, Dr. Tarak Srivastava

  9. Cinacalcet as adjunctive therapy for hereditary 1,25-dihydroxyvitamin D-resistant rickets

    Article • Journal of Bone and Mineral Research, April 2013, Wiley

    Dr. Tarak Srivastava

  10. Pediatric Primary Urolithiasis: 12-Year Experience at a Midwestern Children's Hospital

    Article • The Journal of Urology, April 2013, Elsevier

    Dr. Tarak Srivastava

  11. Renal Function and Proteinuria after Successful Immunosuppressive Therapies in Patients with FSGS

    Article • Clinical Journal of the American Society of Nephrology, November 2012, American Society of Nephrology

    Dr. Tarak Srivastava, Dr Marva Moxey-Mims, Dr Howard Trachtman

  12. Bisphosphonates for Pain Management in Children With Benign Cartilage Tumors

    Article • Clinical Journal of Pain, January 2012, Wolters Kluwer Health

    Dr. Tarak Srivastava

  13. Serum 25-hydroxyvitamin D level and acute-phase reaction following initial intravenous bisphosphonate

    Article • Journal of Bone and Mineral Research, January 2011, Wiley

    Dr. Tarak Srivastava

  14. Parathyroid-hormone-related protein-mediated hypercalcemia in benign congenital mesoblastic nephroma

    Article • Pediatric Nephrology, December 2010, Springer Science + Business Media

    Dr. Tarak Srivastava

  15. Prostaglandin E2 is crucial in the response of podocytes to fluid flow shear stress

    Article • Journal of Cell Communication and Signaling, April 2010, Springer Science + Business Media

    Dr. Tarak Srivastava

  16. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor

    Article • Molecular Genetics and Metabolism, January 2010, Elsevier

    Dr. Tarak Srivastava

  17. Urine Calcium/Citrate Ratio in Children With Hypercalciuric Stones

    Article • Pediatric Research, July 2009, Nature

    Dr. Tarak Srivastava

  18. Diagnosis and management of hypercalciuria in children

    Article • Current Opinion in Pediatrics, April 2009, Wolters Kluwer Health

    Dr. Tarak Srivastava

  19. Atorvastatin May Have No Effect on Acute Phase Reaction in Children After Intravenous Bisphosphonate Infusion

    Article • Journal of Bone and Mineral Research, February 2009, Wiley

    Dr. Tarak Srivastava

  20. Impact of Standardization of Creatinine Methodology on the Assessment of Glomerular Filtration Rate in Children

    Article • Pediatric Research, January 2009, Nature

    Dr. Tarak Srivastava

  21. Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates

    Article • Pediatric Nephrology, October 2008, Springer Science + Business Media

    Dr. Tarak Srivastava

  22. Use of the Multipurpose Drainage Catheter for the Provision of Acute Peritoneal Dialysis in Infants and Children

    Article • American Journal of Kidney Diseases, May 2007, Elsevier

    Dr. Tarak Srivastava

  23. Pathophysiology of hypercalciuria in children

    Article • Pediatric Nephrology, April 2007, Springer Science + Business Media

    Dr. Tarak Srivastava

  24. Measurement of urea nitrogen and creatinine concentrations in peritoneal dialysate and other body fluids using the Vitros analyzer

    Article • Clinical Biochemistry, March 2007, Elsevier

    Dr. Tarak Srivastava

  25. Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children

    Article • Pediatric Nephrology, October 2006, Springer Science + Business Media

    Dr. Tarak Srivastava

  26. Urolithiasis

    Article • October 2006, Informa Healthcare

    Dr. Tarak Srivastava

  27. Essentials of laboratory medicine for the nephrology clinician

    Article • Pediatric Nephrology, September 2006, Springer Science + Business Media

    Dr. Tarak Srivastava

  28. Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type

    Article • Pediatric Nephrology, March 2006, Springer Science + Business Media

    Dr. Tarak Srivastava

  29. Nondiabetic consequences of obesity on kidney

    Article • Pediatric Nephrology, February 2006, Springer Science + Business Media

    Dr. Tarak Srivastava

  30. Collection under paraffin is not necessary for stability of urine pH over 24�h

    Article • Pediatric Nephrology, February 2004, Springer Science + Business Media

    Dr. Tarak Srivastava

  31. The role of bisphosphonates in diseases of childhood

    Article • European Journal of Pediatrics, November 2003, Springer Science + Business Media

    Dr. Tarak Srivastava

  32. Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood

    Article • Kidney International, April 2003, Elsevier

    Dr. Tarak Srivastava

  33. Childhood hyperuricemia and acute renal failure resulting from a missense mutation in theHPRT gene

    Article • American Journal of Medical Genetics, February 2002, Wiley

    Dr. Tarak Srivastava

  34. Synaptopodin expression in idiopathic nephrotic syndrome of childhood

    Article • Kidney International, January 2001, Elsevier

    Dr. Tarak Srivastava

  35. C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis

    Article • Pediatric Nephrology, August 2000, Springer Science + Business Media

    Dr. Tarak Srivastava

  36. Posttransplant lymphoproliferative disorder in pediatric renal transplantation

    Article • Pediatric Nephrology, November 1999, Springer Science + Business Media

    Dr. Tarak Srivastava

  37. POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS

    Article • Transplantation, April 1999, Wolters Kluwer Health

    Dr. Tarak Srivastava

  38. High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood

    Article • Pediatric Nephrology, February 1999, Springer Science + Business Media

    Dr. Tarak Srivastava